| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/29/2011 | CA2412750C Substituted metal-phthalocyanines, their preparation and the use thereof |
| 03/29/2011 | CA2397016C Use of lipid conjugates in the treatment of disease |
| 03/29/2011 | CA2390652C Human circulating virus-inhibiting peptide (virip) and its use |
| 03/29/2011 | CA2390164C Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/29/2011 | CA2387611C Manufacture of polyglutamate-therapeutic agent conjugates |
| 03/29/2011 | CA2345276C Flt4 (vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 03/29/2011 | CA2323058C Methods for the diagnosis and treatment of lung cancer by detection of proto-oncogene overexpression |
| 03/29/2011 | CA2263798C G-coupled receptor showing selective affinity for atp |
| 03/29/2011 | CA2239151C Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
| 03/29/2011 | CA2207815C Modulators of the function of fas/apo1 receptors |
| 03/29/2011 | CA2165573C Anti-.alpha.v-integrin monoclonal antibody |
| 03/24/2011 | WO2011035143A2 Methods and compositions for inhibiting rho-mediated diseases and conditions |
| 03/24/2011 | WO2011034934A1 Abt-263 crystalline forms and solvates for use in treating bcl-2 protein related diseases |
| 03/24/2011 | WO2011034919A2 Sh2 domain profiling to characterize tyrosine phosphorylation signaling in cancer |
| 03/24/2011 | WO2011034887A2 A method for treating neuropathic pain |
| 03/24/2011 | WO2011034834A2 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same |
| 03/24/2011 | WO2011034775A2 Methods for treating brain tumors |
| 03/24/2011 | WO2011034583A2 Inhibition of endosomal toll-like receptor activation |
| 03/24/2011 | WO2011034504A1 Solid forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and methods of making the same |
| 03/24/2011 | WO2011034465A1 A pharmaceutical composition for peroral administration of diindolylmethane |
| 03/24/2011 | WO2011034394A2 Oxaliplatin nanoparticles and method for preparing same |
| 03/24/2011 | WO2011034215A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY |
| 03/24/2011 | WO2011034210A1 Pharmaceutical combination for treating tumor |
| 03/24/2011 | WO2011033265A1 Pharmaceutical compounds |
| 03/24/2011 | WO2011033229A1 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof |
| 03/24/2011 | WO2011033225A2 Substituted 3-amino-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 03/24/2011 | WO2011033105A1 Dosage regimen for administering an epcamxcd3 bispecific antibody |
| 03/24/2011 | WO2011033053A1 Macrocyclic inhibitors of jak |
| 03/24/2011 | WO2011032563A1 Medical use of spla2 hydrolysable liposomes |
| 03/24/2011 | WO2011032491A1 Selfheal extraction containing rosmarinic acid, its preparation method and its use for preparation of medicine for precaution or treatment of cancer metastasis after surgery |
| 03/24/2011 | WO2011032489A1 Method of using poxvirus vector hiv vaccine combined with adenoviral vector hiv vaccine and the uses thereof |
| 03/24/2011 | WO2011032296A1 Methods and compositions for the diagnosis and treatment of thyroid cancer |
| 03/24/2011 | WO2011012885A9 Fulvestrant in a dosage of 500mg for the treatment of advanced breast cancer |
| 03/24/2011 | WO2011009095A8 Crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1, 1-dicarboxamide |
| 03/24/2011 | WO2010148007A9 Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof |
| 03/24/2011 | WO2010136000A3 Steroide anionic compounds, method of their production, usage and pharmaceutical preparation involving them |
| 03/24/2011 | WO2010132684A3 Inhibitors of inv(16) leukemia |
| 03/24/2011 | WO2010129053A3 Egfr inhibitors and methods of treating disorders |
| 03/24/2011 | WO2010129048A3 Therapeutic compounds |
| 03/24/2011 | WO2010123591A3 Small molecule inhibitors of nads, namnat, and nmnat |
| 03/24/2011 | WO2010123583A3 1-aryl or 1-heteroaryl-pyrido[b]indoles and uses thereof |
| 03/24/2011 | WO2010120872A3 Method of decreasing pro-adam10 secretase and/or beta secretase levels |
| 03/24/2011 | WO2010118200A3 Liposomal formulations of tocopheryl amides |
| 03/24/2011 | WO2010111653A3 Modulating ires-mediated translation |
| 03/24/2011 | WO2010108125A3 Psma-targeting compounds and uses thereof |
| 03/24/2011 | WO2010091384A3 Cadherin-11 inhibitors and methods of use thereof |
| 03/24/2011 | WO2010022358A8 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazolo[4,5- c]pyridinyl)purine and purinone derivatives for immunosuppression |
| 03/24/2011 | US20110071612 Anti-angiogenic compositions and methods of use |
| 03/24/2011 | US20110071216 Reconstitutable reverse thermal gelling polymers |
| 03/24/2011 | US20110071215 Compositions and methods for diagnosis, prognosis and treatment of mesothelioma |
| 03/24/2011 | US20110071214 Methods and compositions for the treatment of cancer |
| 03/24/2011 | US20110071212 P185neu-encoding dna and therapeutical uses thereof |
| 03/24/2011 | US20110071211 MicroRNA (miRNA) And Downstream Targets For Diagnostic And Therapeutic Purposes |
| 03/24/2011 | US20110071210 Methods and compositions for the treatment of cancer or other diseases |
| 03/24/2011 | US20110071208 Lipid encapsulated dicer-substrate interfering rna |
| 03/24/2011 | US20110071196 Compounds Which Selectively Modulate The CB2 Receptor |
| 03/24/2011 | US20110071195 Novel alkene oxindole derivatives |
| 03/24/2011 | US20110071182 Inhibitors of AKT Activity |
| 03/24/2011 | US20110071179 Macrocyclic inhibitors of jak |
| 03/24/2011 | US20110071178 Methods and Compounds for Modulating Cannabinoid Activity |
| 03/24/2011 | US20110071174 Substituted quinazolines |
| 03/24/2011 | US20110071172 Substituted quinazolines as blood platelet lowering agents |
| 03/24/2011 | US20110071171 2h- pyrimido [2, 1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents |
| 03/24/2011 | US20110071170 Tricyclic pyrazolopyrimidine derivatives |
| 03/24/2011 | US20110071169 Preparation of polymorphic form of lapatinib ditosylate |
| 03/24/2011 | US20110071165 Aza- and polyazanthranyl amides and their use as medicaments |
| 03/24/2011 | US20110071158 New compounds |
| 03/24/2011 | US20110071157 Role of N-2-Hydroxy-Ethyl-Piperazine-N'-2-Ethane Sulfonic Acid (HEPES) in Pain Control and Reversal of Demyelinization Injury |
| 03/24/2011 | US20110071153 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors |
| 03/24/2011 | US20110071151 Abt-263 crystalline forms |
| 03/24/2011 | US20110071149 Selective kinase inhibitors |
| 03/24/2011 | US20110071147 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid amides |
| 03/24/2011 | US20110071145 Raf Modulators And Methods Of Use |
| 03/24/2011 | US20110071144 Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/24/2011 | US20110071142 Identification and use of small molecules to modulate transcription factor function and to treat transcription factor associated diseases |
| 03/24/2011 | US20110071136 Novel tricyclic protein kinase modulators |
| 03/24/2011 | US20110071134 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases |
| 03/24/2011 | US20110071133 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 03/24/2011 | US20110071127 Compounds Which Modulate the CB2 Receptor |
| 03/24/2011 | US20110071125 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity |
| 03/24/2011 | US20110071115 Pharmaceutically useful heterocycle-substituted lactams |
| 03/24/2011 | US20110071113 Thiazole Derivatives and Use Thereof |
| 03/24/2011 | US20110071100 Sulfobetaines for cancer, obesity, macular degeneration, neurodegenerative diseases |
| 03/24/2011 | US20110071099 Cationic Ceramides, And Analogs Thereof, And Their Use For Preventing Or Treating Cancer |
| 03/24/2011 | US20110071097 Cephalotaxus esters, methods of synthesis, and uses thereof |
| 03/24/2011 | US20110071094 (d)-allose inducing programmed cell death in hormone refractory prostate cancer lines |
| 03/24/2011 | US20110071090 Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle |
| 03/24/2011 | US20110071089 Peptide composition for cancer treatment by inhibiting trpv6 calcium channel activity |
| 03/24/2011 | US20110071087 Polypeptides having modulatory effects on cells |
| 03/24/2011 | US20110071083 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells |
| 03/24/2011 | US20110071082 Long lasting anti-angiogenic peptides |
| 03/24/2011 | US20110070317 Pyrrolopyridines as kinase inhibitors |
| 03/24/2011 | US20110070314 Methods for treating brain tumors |
| 03/24/2011 | US20110070313 Methods of inducing cell differentiation with placental extracts |
| 03/24/2011 | US20110070311 Producing a sustained-release preparation |
| 03/24/2011 | US20110070298 Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance |
| 03/24/2011 | US20110070295 Methods for the preparation of liposomes comprising docetaxel |
| 03/24/2011 | US20110070294 Methods for the Administration of Drugs Using Liposomes |
| 03/24/2011 | US20110070293 Methods for the Preparation of Liposomes Comprising Docetaxel |
| 03/24/2011 | US20110070292 Methods For The Preparation Of Liposomes |